{'fraction_non_alphanumeric': 0.031799729364005415, 'fraction_numerical': 0.02435723951285521, 'mean_word_length': 5.375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Evaluation of serum 1,5-anhydroglucitol levels as hyperglycemic indicator in patients with newly diagnosed type 2 diabetes mellitus

Background and Objectives: 1,5-Anhydroglucitol (1,5-AG) is an emerging marker in the acute assessment of glycemia. 1,5-AG has been shown to be associated with glycemic excursions and also been found to have association with microvascular complications of diabetes and atherosclerosis. This study aimed to evaluate serum 1,5-AG concentration in newly diagnosed type 2 diabetes patients and find the correlation between serum 1,5-AG concentration and blood glucose concentration. Materials and Methods: The study group consisted of 60 type 2 diabetes patients aged 35–55 years and 60 age- and sex-matched controls. 1,5-AG plasma level, HbA1c, fructosamine, and blood glucose were measured in all subjects. Data analysis was done using SPSS software. Results and Discussion: 1,5-AG levels were significantly lower in patients with diabetes mellitus when compared with the control group. 1,5-AG serum level negatively correlated with postprandial blood glucose. The linear regression analysis revealed that 1,5-AG had a linear association with postprandial blood glucose. Conclusion: Serum 1,5-AG levels significantly decreased with an increase in plasma glucose concentrations in patients with diabetes mellitus. Thus monitoring of serum 1,5-AG level may be useful for evaluating glycemic control in patients with newly diagnosed diabetes mellitus.